Advanced progress in research and diagnosis of gastric cancer in 2022

Gastric cancer is one of the malignant tumors with high incidence in China, with a 5-year relative survival rate of about 40%, which is characterized by low early diagnosis rate, large tumor load, high heterogeneity and poor prognosis. In the past 20 years, the multidisciplinary team model and indiv...

Full description

Bibliographic Details
Main Author: JIANG Jinling, ZHOU Chenfei, WANG Chao, ZHAO Liqin, WU Junwei, ZHANG Jun
Format: Article
Language:English
Published: Editorial Office of China Oncology 2023-04-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1684137939099-982572506.pdf